Evidence map›Paper›PMID 35123029›Full record

ArticleContemporary clinical trials2022

Two weights make a wrong: Cluster randomized trials with variable cluster sizes and heterogeneous treatment effects.

Xueqi Wang, Elizabeth L Turner, Fan Li, Rui Wang, Jonathan Moyer, Andrea J Cook, David M Murray, Patrick J Heagerty

Open access · greenAbstract read
In one paragraph

Article in Contemporary clinical trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Model-robust standardization in stepped wedge cluster randomized trials.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2026
    Article
  6. Use of estimands in cluster randomised trials: A review.Clinical trials (London, England) · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Demystifying estimands in cluster-randomised trials.Statistical methods in medical research · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Xueqi WangDepartment of Biostatistics & Bioinformatics and Duke Global Health Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: xueqi.wang@duke.edu.
Elizabeth L TurnerDepartment of Biostatistics & Bioinformatics and Duke Global Health Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address: liz.turner@duke.edu.
Fan LiDepartment of Biostatistics and Center for Methods in Implementation & Prevention Science, Yale University School of Public Health, New Haven, CT, USA. Electronic address: fan.f.li@yale.edu.
Rui WangDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA, USA; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. Electronic address: rwang@hsph.harvard.edu.
Jonathan MoyerOffice of Disease Prevention, National Institutes of Health, Bethesda, MD, USA. Electronic address: jonathan.moyer@nih.gov.
Andrea J CookBiostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA; Department of Biostatistics, University of Washington, Seattle, WA, USA. Electronic address: Andrea.J.Cook@kp.org.
David M MurrayOffice of Disease Prevention, National Institutes of Health, Bethesda, MD, USA. Electronic address: david.murray2@nih.gov.
Patrick J HeagertyDepartment of Biostatistics, University of Washington, Seattle, WA, USA. Electronic address: heagerty@uw.edu.
Duke University · USOffice of Disease Prevention · USHarvard Pilgrim Health Care · USKaiser Permanente Washington Health Research Institute · USUniversity of Washington · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NIH Health Care Systems Research Collaboratory-Coordinating Center (U24)U24AT009676 · NCCIH · DUKE UNIVERSITY · PI LESLEY H CURTIS, Adrian Hernandez · 2017 to 2026
$21.5M
HEAL Collaboratory Resource Coordinating Center (PRISM) (U24): Bioethics SupplementU24AT010961 · NCCIH · DUKE UNIVERSITY · PI CURTIS, LESLEY H, HERNANDEZ, ADRIAN · 2019 to 2021
$6.4M
Strategies and Opportunities to Stop Colon Cancer in Priority PopulationsUH2AT007782 · NCCIH · KAISER FOUNDATION RESEARCH INSTITUTE · PI CORONADO, GLORIA D, DEVOE, JENNIFER E · 2012 to 2013
$859k
NCATS NIH HHS UL1 TR001863NCCIH NIH HHS U24 AT009676NCCIH NIH HHS U24 AT010961NCCIH NIH HHS UH2 AT007782
6 · The paper itself

Abstract

In cluster randomized trials (CRTs), the hierarchical nesting of participants (level 1) within clusters (level 2) leads to two conceptual populations: clusters and participants. When cluster sizes vary and the goal is to generalize to a hypothetical population of clusters, the unit average treatment effect (UATE), which averages equally at the cluster level rather than equally at the participant level, is a common estimand of interest. From an analytic perspective, when a generalized estimating equations (GEE) framework is used to obtain averaged treatment effect estimates for CRTs with variable cluster sizes, it is natural to specify an inverse cluster size weighted analysis so that each cluster contributes equally and to adopt an exchangeable working correlation matrix to account for within-cluster correlation. However, such an approach essentially uses two distinct weights in the analysis (i.e. both cluster size weights and covariance weights) and, in this article, we caution that it will lead to biased and/or inefficient treatment effect estimates for the UATE estimand. That is, two weights "make a wrong" or lead to poor estimation characteristics. These findings are based on theoretical derivations, corroborated via a simulation study, and illustrated using data from a CRT of a colorectal cancer screening program. We show that, an analysis with both an independence working correlation matrix and weighting by inverse cluster size is the only approach that always provides valid results for estimation of the UATE in CRTs with variable cluster sizes.

Indexed as

Early Detection of CancerModels, StatisticalCluster AnalysisComputer SimulationHumansRandomized Controlled Trials as TopicSample SizeCluster randomized trialsGeneralized estimating equationsHeterogeneity of treatment effectsUnit average treatment effectWeighting

Identifiers

PMID35123029
PMCPMC8936048
OpenAlexW4210552608

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.